Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Contract Win

20 Mar 2007 07:00

Embargoed Release: 07:00hrs Tuesday 20th March 2007

Sopheon plc (`Sopheon') Land O'Lakes to Deploy Sopheon's Product Life Cycle Management Solution

Leading Consumer Goods Company Adopts Accolade‚® to Automate Stage-Gate‚® Process

and Support Focus on High-Value Products

Sopheon, the international software and services company, announces today that Land O'Lakes, Inc., a leading dairy co-operative, is implementing Sopheon's Accolade product life cycle management (`PLM') system as the technology foundation for its product innovation processes. The solution will be used initially within the company's Dairy Foods business unit, where it will support cross-functional teams responsible for developing and commercializing new products. Plans include subsequent enterprise-wide deployment.

Headquartered in St. Paul, Minn., Land O'Lakes generates annual revenues of more than $7 billion and is one of the largest dairy co-ops in the U.S. It markets milk, spreads, cheeses and deli products to consumers, food services and food manufacturers throughout the world.

Land O'Lakes also offers an extensive line of agricultural supplies and state-of-the-art production, distribution and business services. During its 86-year history, the company has established a reputation for quality, strong brands and innovation.

Land O'Lakes has stated that one of its principal strategic goals is to incorporate best practices into all aspects of its operations. This focus is part of an overarching plan to drive additional revenues and profit growth from the company's core businesses. Actions include an initiative aimed at enhancing the process for product innovation.

Sopheon's system will be used to automate the Stage-Gate product development methodology being deployed by Land O'Lakes. Accolade will streamline the innovation process, making it easier to use and reducing the administrative burden otherwise associated with its implementation. Step-by-step task guidelines and Land O'Lakes' best-practice based report templates have been embedded in the software to support efficient process execution and successful completion of deliverables. The system will strengthen innovation process governance by providing decision support and controls that enable more informed prioritization of product development projects.

"Innovation is essential to our business success," said Tom Grueztmacher, vice-president of research and development at Land O'Lakes. "Accolade will automate our product development process and assist us in setting project priorities. Its capabilities will help to ensure that the right new products get to market, and get there on time. In designing our system we benefited from Sopheon's domain expertise in product-development best practices and the fact that they have installed and supported similar, successful systems for a substantial number of consumer packaged goods (CPG) companies. Their industry-specific know-how gave us an important leg up in developing a process in which we can have confidence."

"Business process improvement is a central strategic thrust for most companies today," said Andy Michuda, CEO of Sopheon. "And recent surveys consistently place product and service development processes among the top improvement priorities. The reasons are all about business. Improved innovation means substantial increases in portfolio net-present-value and, ultimately, higher profits, revenues and stakeholder returns. Land O'Lakes' aim is to compete not only with superior products, but also with superior product development processes. We are committed to helping them achieve that goal."

Land O'Lakes' deployment continues an extended pattern of Accolade adoption by major consumer goods manufacturers. Ten of the 100 companies comprising Consumer Goods Technology magazine's current registry of the world's largest consumer goods producers are using the Sopheon system. Examples include Cadbury Schweppes, Electrolux, Nestle, and Reckitt Benckiser.

-Ends-

Accolade‚® is a registered trademark of Sopheon plc.

Stage-Gate‚® is a registered trademark of the Product Development Institute.

All other trademarks and registered trademarks are the sole

property of their respective owners.

About Land O'Lakes

Land O'Lakes, Inc. is a farmer-owned food and agricultural cooperative with annual sales of more than $7 billion. Land O'Lakes does business in all 50 states and more than 50 countries. It is a leading marketer of a full line of dairy-based consumer, foodservice and food ingredient products across the United States; serves its international customers with a variety of food and animal feed ingredients; and provides farmers and ranchers with an extensive line of agricultural supplies (feed, seed, crop nutrients and crop protection products) and services. Land O'Lakes also provides agricultural assistance and technical training in more than 25 developing nations. For more information, please visit www.landolakesinc.com.

About Sopheon

Sopheon is an international provider of software and services that help organizations improve the business impact of product innovation. Sopheon's Accolade system automates and governs the innovation process, enabling companies to increase revenue and profits from new products. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com.

For further information contact:

Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Andrew Tan Hansard Group Tel : + 44 (0) 207 245 1100 + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010

SOPHEON PLC
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.